By Sam van de Schootbrugge 04-11-2020
In: deep-dives | Markets and Investing

Do Analysts Top Pick Recommendations Make Money?

(5 min read)
Resize text:


Investment firms and brokerage houses are increasingly using ‘top picks’ to supplement stock recommendations (Chart 1). These ‘highest-conviction best ideas’ are typically announced December-February and garner significantly more media attention.

An NBER paper examines these top picks’ stock performance and whether analysts use them to inflate the value of their clients’ stock prices. They find the following:

Top picks generate greater excess returns than traditional buy recommendations (17% annualised excess returns (1.33% monthly), compared with 6.5% for buy recommendations).
They are characterised by higher expected EPS and stock return performance, tend to be issued by relatively larger firms, are more likely to be growth and momentum stocks, and are more visible to the investment community. Further, their selection is negatively associated with uncertainty and risk.
Bad top picks are more likely to be ‘strategic selections’. That is, they are more likely to be affiliated with the investment banking arm of the analyst’s brokerage house. However, the analysts recommending these bad top picks are generally penalised by demotions.

TO READ THIS DEEP DIVE
SUBSCRIBE TO MACRO HIVE PRIME

£39/month thereafter

For access to our Slack Chat Room, where we discuss all things markets with our researchers and subscribers

START YOUR FREE TRIAL


MOST READ

ECB Preview: Biding Time Until June (2 min read)

By Caroline Grady | Apr 20, 2021
Stepped up PEPP purchases since the 11 March ECB meeting leave little need for any policy changes at this week’s governing council meeting...

Russia Sanctions: The Shock That Never Came (5 min read)

By Tatiana Orlova | Apr 16, 2021
The most important measure bars US entities from newly issued local sovereign debt, effective from 14 June. The ban includes debt issued by the CBR...

Weekly Vaccination Update: J&J Pause and EU Supply Schedule (1 min read)

By Sam van de Schootbrugge | Apr 14, 2021
In this prime tracker, we review the latest vaccine developments globally. This week, we’ve added some brief commentary...

PREMIUM CONTENT

ECB Preview: Biding Time Until June (2 min read)

By Caroline Grady | Apr 20, 2021
Summary Thursday’s ECB meeting is unlikely to…

Five Things You Did Not Know About China (2 min read)

By Bilal Hafeez | Apr 13, 2021
China is a global economic superpower, yet…

Want To Join Our Community Of Leading Investors And Researchers In Our Slack Chat Room?